Christopher G. Hayes's Insider Trades & SAST Disclosures
Christopher G. Hayes's most recent trade in Verrica Pharmaceuticals Inc was a trade of 250,000 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on March 14, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Christopher G. Hayes.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Verrica Pharmaceuticals Inc | Christopher G. Hayes | CHIEF LEGAL OFFICER | 14 Mar 2025 | 250,000 | 250,000 | - | - | Employee Stock Option (right to buy) | ||
| Verrica Pharmaceuticals Inc | Christopher G. Hayes | CHIEF LEGAL OFFICER | 14 Mar 2025 | 4,315 | 176,458 (0%) | 0% | 0.7 | 2,805 | Common Stock | |
| Verrica Pharmaceuticals Inc | Christopher G. Hayes | CHIEF LEGAL OFFICER | 09 Oct 2024 | 50,000 | 50,000 | - | - | Employee Stock Option (right to buy) | ||
| Verrica Pharmaceuticals Inc | Christopher G. Hayes | CHIEF LEGAL OFFICER | 26 Aug 2024 | 26,183 | 115,303 (0%) | 0% | 2.7 | 69,647 | Common Stock | |
| Verrica Pharmaceuticals Inc | Christopher G. Hayes | CHIEF LEGAL OFFICER | 26 Aug 2024 | 9,530 | 105,773 (0%) | 0% | 2.5 | 23,444 | Common Stock | |
| Verrica Pharmaceuticals Inc | Christopher G. Hayes | CHIEF LEGAL OFFICER | 22 Jul 2024 | 21,649 | 141,577 (0%) | 0% | 7.1 | 152,842 | Common Stock | |
| Verrica Pharmaceuticals Inc | Christopher G. Hayes | CHIEF LEGAL OFFICER | 22 Jul 2024 | 91 | 141,486 (0%) | 0% | 7.0 | 635 | Common Stock | |
| Verrica Pharmaceuticals Inc | Christopher G. Hayes | CHIEF LEGAL OFFICER | 15 Mar 2024 | 80,000 | 80,000 | - | - | Employee Stock Option (right to buy) | ||
| Verrica Pharmaceuticals Inc | Christopher G. Hayes | CHIEF LEGAL OFFICER | 15 Mar 2024 | 40,000 | 163,226 (0%) | 0% | 0 | Common Stock | ||
| Verrica Pharmaceuticals Inc | Christopher G. Hayes | Chief Legal Officer | 14 Nov 2023 | 22,141 | 134,784 (0%) | 0% | 2.9 | 64,873 | Common Stock | |
| Verrica Pharmaceuticals Inc | Christopher G. Hayes | Chief Legal Officer | 14 Nov 2023 | 11,558 | 123,226 (0%) | 0% | 3.0 | 34,327 | Common Stock | |
| Verrica Pharmaceuticals Inc | Christopher G. Hayes | CHIEF LEGAL OFFICER | 24 Aug 2023 | 150,000 | 231,925 (0%) | 0% | 0 | Common Stock | ||
| Verrica Pharmaceuticals Inc | Christopher G. Hayes | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Aug 2023 | 75,000 | 156,925 (0%) | 0% | 0 | Common Stock | |
| Verrica Pharmaceuticals Inc | Christopher G. Hayes | Chief Legal Officer | 21 Jul 2023 | 100,000 | 115,714 (0%) | 0% | 0 | Common Stock | ||
| Verrica Pharmaceuticals Inc | Christopher G. Hayes | Chief Legal Officer | 21 Jul 2023 | 33,789 | 81,925 (0%) | 0% | 4.8 | 163,201 | Common Stock | |
| Verrica Pharmaceuticals Inc | Christopher G. Hayes | Chief Legal Officer | 01 Mar 2023 | 135,000 | 135,000 | - | - | Employee Stock Option (right to buy) | ||
| Verrica Pharmaceuticals Inc | Christopher G. Hayes | Chief Legal Officer | 11 Jul 2022 | 7,500 | 15,714 (0%) | 0% | 3.4 | 25,500 | Common Stock | |
| Verrica Pharmaceuticals Inc | Christopher G. Hayes | Chief Legal Officer | 05 Jul 2022 | 5,714 | 8,214 (0%) | 0% | 2.1 | 11,999 | Common Stock | |
| Verrica Pharmaceuticals Inc | Christopher G. Hayes | Chief Legal Officer | 24 Feb 2022 | 75,000 | 75,000 | - | - | Employee Stock Option (right to buy) | ||
| Verrica Pharmaceuticals Inc | Christopher G. Hayes | Chief Legal Officer | 04 Jun 2021 | 2,500 | 2,500 (0%) | 0% | 9.8 | 24,475 | Common Stock | |
| Verrica Pharmaceuticals Inc | Christopher G. Hayes | Chief Legal Officer | 01 Mar 2021 | 65,000 | 65,000 | - | - | Employee Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges